Organogenesis Holdings Inc. Class A (ORGO)
NASDAQ: ORGOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
ORGO stock chart
Technical analysisKey statistics
All statistics- Market cap
- $169.85M
- EPS (TTM)
- -$0.83
- Dividend yield
- None
- 52-week range
- 1.28 – 7.08
- Day range
- 1.30 – 1.39
- Volume / Avg
- 772.02K / 772.97K
- Beta
- —
- Shares outstanding
- 128.67M
- Next earnings
- Nov 5, 2026
52-week range
ORGO stock today
Shares of Organogenesis (ORGO) finished lower on Oct 7 at $1.32, a drop of 1.49% or $0.02 per share, versus the S&P 500's 0.22% decline. Shares are 81.3% below their 52-week high of $7.08, set on Nov 11, 2025 and 3.5% above the 52-week low of $1.28, near the bottom of the past year's range. ORGO is down 74.5% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 68.1%.
Organogenesis has posted a net loss over the last twelve months (EPS of -$0.83), so its P/E ratio is not meaningful. Organogenesis's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Organogenesis
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2016
Earnings
Earnings history- Next report
- Nov 5, 2026
Organogenesis peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| YARWYarrow Bioscience Inc. | 18.78 | +0.24% | $174.69M | vs ORGO |
| VRXAVeraxa Biotech AG | 1.20 | +11.11% | $169.69M | vs ORGO |
| DERMJourney Medical Corporation | 5.95 | -3.41% | $167.94M | vs ORGO |
| PEPGPepGen Inc. | 2.40 | +3.90% | $166.01M | vs ORGO |
| CNTNCanton Strategic Holdings Inc. | 2.26 | -3.42% | $180.08M | vs ORGO |
| ADCTADC Therapeutics SA | 1.42 | +11.81% | $181.29M | vs ORGO |
| CUECue Biopharma Inc. | 22.51 | -2.72% | $163.52M | vs ORGO |
| ORMPOramed Pharmaceuticals Inc. | 4.37 | -0.23% | $181.78M | vs ORGO |
Indexes, lists and sector
Organogenesis stock FAQ
What is Organogenesis's stock price today?
ORGO last traded at $1.32 as of Oct 7, 4:00 PM EDT, down 1.49% on the day. Prices are delayed at least 15 minutes.
When is Organogenesis's next earnings date?
Organogenesis is expected to report earnings on Thursday, November 5, 2026.
What is the ORGO 52-week high?
The 52-week high for ORGO is $7.08 and the 52-week low is $1.28. The stock is currently 81.3% below its high.